| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 10/07/2004 | WO2004084876A2 Use of compounds for the prevention of drug-induced cell toxicity |
| 10/07/2004 | WO2004084873A1 Oral delivery system comprising an antibacterial and an anti-inflammatory agent |
| 10/07/2004 | WO2004084865A1 Formulations comprising an active ingredient and cocoa powder and use thereof |
| 10/07/2004 | WO2004084864A1 Formulations comprising tolterodine and cocoa powder and use thereof |
| 10/07/2004 | WO2004084828A2 Keratinocyte-fibrocyte concomitant grafting for wound healing |
| 10/07/2004 | WO2004084825A2 Wound healing composition derived from low platelet concentration plasma |
| 10/07/2004 | WO2004069999A3 Screening method |
| 10/07/2004 | WO2004066924A3 Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid |
| 10/07/2004 | WO2004062729A8 Pharmaceutical combination for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases |
| 10/07/2004 | WO2004060345A3 Dispersible pharmaceutical compositions |
| 10/07/2004 | WO2004058163A3 Pharmaceutical compositions and method of treating parkinson's disease |
| 10/07/2004 | WO2004041176A3 The use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis c, bovine viral diarrhea and classical swine fever virus |
| 10/07/2004 | WO2004039322A3 Novel combination therapy for schizophrenia focused on improved cognition: 5-ht-2a/d2 blockade with adjunctive blockade of prefrontal da reuptake |
| 10/07/2004 | WO2004028466A3 Ketoamide inhibitors in chronic nerve disease |
| 10/07/2004 | WO2004024880A3 AMPDs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 10/07/2004 | WO2004012659A3 Nitrosated proton pump inhibitors, compositions and methods of use |
| 10/07/2004 | WO2004004757A8 Treatment for eye disorder |
| 10/07/2004 | WO2004004640A3 Methods, compositions and kits for treating damage to excitable tissue |
| 10/07/2004 | WO2004002402A3 Administration of acetylcholinesterase inhibitors to the cerebral spinal fluid |
| 10/07/2004 | WO2003074027A8 Self emulsifying drug delivery systems for poorly soluble drugs |
| 10/07/2004 | WO2003072106A8 Use of tyrosine kinase inhibitors for treating substance use disorders |
| 10/07/2004 | WO2003049679A3 Mitotic kinesin inhibitors |
| 10/07/2004 | WO2002092000A3 Hbm variants that modulate bone mass and lipid levels |
| 10/07/2004 | US20040198982 such as (4S)-1-(3-bromophenyl)-N-cyanomethyl)-4-methyl-prolinamide; for treatment of osteoporosis |
| 10/07/2004 | US20040198949 Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 10/07/2004 | US20040198841 Pretreatment before chemotherapy; antiulcer agents for cancer therapy |
| 10/07/2004 | US20040198839 Cardioprotective dosage units |
| 10/07/2004 | US20040198834 Concentrated X-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions |
| 10/07/2004 | US20040198829 Adjust transportation of active material to eye |
| 10/07/2004 | US20040198826 Pharmaceutical combination for treating benign prostatic hyperplasia or for treating abacterial prostatitis |
| 10/07/2004 | US20040198822 Using gabapentin, pregabalin; synergistic mixture with anticholinergic agents |
| 10/07/2004 | US20040198820 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity |
| 10/07/2004 | US20040198817 Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension |
| 10/07/2004 | US20040198816 Administering mixture of anesthetic and adrenergic receptor antagonist; reverse with low dosage of adrenergic receptor antagonist; used for hair grafting |
| 10/07/2004 | US20040198806 Antiproliferative agents; synergistic mixture of anticarcinogenic agents with antiemetic |
| 10/07/2004 | US20040198803 Method for reducing intraocular pressure using indole derivatives |
| 10/07/2004 | US20040198799 Methods of increasing endogenous testosterone levels |
| 10/07/2004 | US20040198788 Synergistic mixture with acylcoenzyme: cholesterol transferase inhibitor; arteriosclerosis; antiischemic agents; cardiovascular disorders |
| 10/07/2004 | US20040198781 Carbonic anhydrase inhibitor |
| 10/07/2004 | US20040198753 administering adenosine receptor antagonist ; side effect reduction; parkinson's disease |
| 10/07/2004 | US20040198752 Administering retinoids with epidermal growth factor receptor inhibitors |
| 10/07/2004 | US20040198751 Pyrazolo-pyrimidine compound; anticancer agents |
| 10/07/2004 | US20040198749 Methods of using sodium channel blockers |
| 10/07/2004 | US20040198748 Antihistamines; bronchodilators; antiinflammatory agents; inflammatory bowel disorders |
| 10/07/2004 | US20040198743 Administering synergistic mixture |
| 10/07/2004 | US20040198740 Therapies relating to combinations of aldose reductase inhibitors and cyclooxygenase-2 |
| 10/07/2004 | US20040198739 Prevention reproduction of virus |
| 10/07/2004 | US20040198733 Obesity; antidiabetic agents; cardiovascular disorders; antilipemic agentsl circadian rhythm disorders; hypotensive agents; antidepressants; anxiolytic agents |
| 10/07/2004 | US20040198732 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals |
| 10/07/2004 | US20040198731 Antidiabetic agents; cardiovascular disorders; anticholesterol agents; antidepressants; schizophrenia; antilipemic agents; circidian rhythm disorders |
| 10/07/2004 | US20040198719 Antagonist of MCP-1 function, and compositions and methods of use thereof |
| 10/07/2004 | US20040198717 4-(trifluoromethyl)-7,8,9,10-tetrahydrochromeno[7,6-b]azepin-2(6H)-one and derivatives;4-(trifluoromethyl)-1,6,7,8,9,10-hexahydro-2H-azepino[3,2-g]quinolin-2-one and derivatives; useful in the treating conditions caused by androgen deficiency such as bone disorders |
| 10/07/2004 | US20040198708 For orienting and positioning a capsule containing a dry powder pharmaceutical formulation ( a short-acting bronchodilator and a corticosteroid) to be administered via inhalation to a patient with a pulmonary disease |
| 10/07/2004 | US20040198704 Compositions and method for treating microbial and parasitic infections in cattle and other animals |
| 10/07/2004 | US20040198695 One or more cartilage- and synovial fluid-enhancing active ingredients with bone-enhancing calcium and phosphorus additives |
| 10/07/2004 | US20040198688 for treatment of atopic conditions (dermatitis, allergies); point mutations |
| 10/07/2004 | US20040198680 Dna bacteria; activate lymphocytes; nucleotide sequences; antigens; administering cytokines |
| 10/07/2004 | US20040198672 a microbiocide and a bioenhancer; 4-((1,3-benzodioxol-6-yl)-1,3-butadien-1-yl)-N-carbonylpiperidine and 3',5-Dihydroxy flavone 7-O- beta -D-galacturonide-4'-O- beta -D-glucopyranoside; reduced antibiotic resistance |
| 10/07/2004 | US20040198671 Estrogenic component comprising estetrol and estetrol-like substances, which has relatively low estrogenic potency, metabolic stability, long half-life; triene steroids; osteoporosis, arteriosclerosis, cognitive disturbances, Alzheimer's disease, peri- or post-menopausal disorders |
| 10/07/2004 | US20040198669 Novel nitrile glycoside useful as a bioenhancer of drugs and nutrients, process of its isolation from moringa oleifera |
| 10/07/2004 | US20040198668 synergistic admnistration of a weight-loss promoting anticonvulsant and a norepinephrine or dopamine agonist; hypotensive, antidiabetic, anticholesterol agents |
| 10/07/2004 | US20040198667 neutralization of diphenhydramine maleate with sodium hydroxide; reacting melted diphenhydramine free base with tannic acid neat or with minimal water; vacuum drying; milling into free-flowing powder; high purity, extended release antihistamine |
| 10/07/2004 | US20040198659 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 10/07/2004 | US20040198658 Stanniocalcin polynucleotides, polypeptides and methods based thereon |
| 10/07/2004 | US20040198656 Methods of screening molecules that are used to prevent cardiovascular diseases |
| 10/07/2004 | US20040198653 administering somatostatin type-1,2 or 5 receptor oligopeptide agonists alone or in synergistic combination; antiproliferative agents |
| 10/07/2004 | US20040198651 Secreted proteins |
| 10/07/2004 | US20040198649 a VR4 peptide, a VR4 polypeptide modulator, a VR4 polynucleotide, or an antisense agent as analgesics or antiarthritic agents for bone and cartilage disorders; rheumatoid and osteoarthritis, osteoperosis; biodrugs |
| 10/07/2004 | US20040198644 Integrin inhibitors for the treatment of eye diseases |
| 10/07/2004 | US20040198642 Glucagon-like peptide-2 activity intensifier and inhibitor mixture; gastrointestinal disorders; small- and irritable bowel syndrome, mucositis and Crohn's disease; appetite suppression; obesity |
| 10/07/2004 | US20040198639 Mixture with non-formaldehyde preservative; microbiocides; chemical resistance; drugs, medical equipment, cosmetics; antiaging, wrinkle resistance; skin disorders |
| 10/07/2004 | US20040198635 Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |
| 10/07/2004 | US20040197889 cell free hepatitis b virus transcription/translation in escherichia plasmid; enzyme inhibitors; mimetics; viricides; shelf life |
| 10/07/2004 | US20040197871 for diagnosing and treating inflammatory bowel disease using purified polypeptide; genetic engineering |
| 10/07/2004 | US20040197847 High throughput screening assays using fatty acid synthetic enzymes |
| 10/07/2004 | US20040197786 Method of examining steroid resnponsiveness |
| 10/07/2004 | US20040197431 Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals |
| 10/07/2004 | US20040197421 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 10/07/2004 | US20040197420 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 10/07/2004 | US20040197419 using combinations of naturally occurring elements selected from certain crystals, gem stones and/or metals for vibrational therapy |
| 10/07/2004 | US20040197412 combining active ingredients with a supercritical carbon dioxide , and separating the active ingredients (antibiotics) from the supercritical fluid to yield a dry powder precipitate |
| 10/07/2004 | US20040197409 a prosthetic device (sleeve) placed on the outside surface of the vessel or graft which then elutes antiproliferative drugs or agents from a drug-eluting matrix material; flexible, cylindrical, bioabsorbing, agent-eluting matrix with a vascular-sized lumen |
| 10/07/2004 | US20040197404 Extended release oral dosage form |
| 10/07/2004 | US20040197398 Dosage forms comprising a CETP inhibitors and an HMG-CoA reductase inhibitor |
| 10/07/2004 | US20040197380 Carbohydrate system and a method for providing nutrition to a diabetic |
| 10/07/2004 | US20040197379 Foods; viscosity lowering polysaccharides; maltodextrin-glucomannan complex; supplying fiber to diabetic individuals |
| 10/07/2004 | US20040197352 Microencapsulaed or enteric coated; therapy for kidney disease; health of gastrointestinal system; probiotic bacteria which reduces creatine or organonitrogen compound |
| 10/07/2004 | US20040197349 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 10/07/2004 | US20040197338 Sequening peptide fragments which bind to proteins; prevention reproduction of respiratory syncytial virus |
| 10/07/2004 | US20040197337 Methods to impair hematologic cancer progenitor cells and compounds related thereto |
| 10/07/2004 | US20040197332 antiproliferative agents; antitumor and anticancer agents; monoclonal antibodies produced by hybridomas cell ling |
| 10/07/2004 | US20040197327 Administering antagonist of receptor on surface of lymphocytes; therapy for multiple sclerosis; antidiabetic agents |
| 10/07/2004 | US20040197325 Antibodies against GPR64 and uses thereof |
| 10/07/2004 | US20040197322 submarine coating; a solvent, a film forming resin, graphite and copper; graphite improves anit-fouling properties of copper; free of organotin |
| 10/07/2004 | US20040197321 Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients |
| 10/07/2004 | US20040197320 Herbal supplement for increased muscle strength and endurance for athletes |
| 10/07/2004 | US20040197319 Wound healing composition derived from low platelet concentration plasma |
| 10/07/2004 | US20040197303 For therapy of inflammation and diseases or conditions associated with autoimmune responses |
| 10/07/2004 | US20040197272 Compositions and methods for therapy for diseases characterized by defective chloride transport |
| 10/07/2004 | US20040197271 Therapy for respiratory system disorders; mixture of adrenergic blocking agent, corticosteroid with propellant; side effect reduction |